MeSH D001327 - autoimmune diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007154:Immune system diseases
D000069281:Autoimmune hypophysitis
0 Companies
0 Drugs
Success rate
D000071698:Latent autoimmune diabetes in adults
0 Companies
0 Drugs
Success rate
D000074079:Undifferentiated connective tissue diseases
0 Companies
0 Drugs
Success rate
D000077733:Immunoglobulin g4-related disease
0 Companies
0 Drugs
Success rate
D000080365:Birdshot chorioretinopathy
0 Companies
0 Drugs
Success rate
D000081012:Autoimmune pancreatitis
0 Companies
0 Drugs
Success rate
D000224:Addison disease
D000744:Hemolytic anemia autoimmune
D001171:Juvenile arthritis
D001172:Rheumatoid arthritis
D003874:Dermatitis herpetiformis
D003922:Type 1 diabetes mellitus
D006111:Graves disease
0 Companies
0 Drugs
Success rate
D008180:Systemic lupus erythematosus
D009879:Sympathetic ophthalmia
0 Companies
0 Drugs
Success rate
D010392:Pemphigus
D013967:Autoimmune thyroiditis
D015433:Membranous glomerulonephritis
0 Companies
0 Drugs
Success rate
D016553:Thrombocytopenic purpura idiopathic
D016736:Antiphospholipid syndrome
0 Companies
0 Drugs
Success rate
D016884:Autoimmune polyendocrinopathies
0 Companies
0 Drugs
Success rate
D019693:Autoimmune hepatitis
0 Companies
0 Drugs
Success rate
D019867:Anti-glomerular basement membrane disease
0 Companies
0 Drugs
Success rate
D056648:Anti-neutrophil cytoplasmic antibody-associated vasculitis
D056735:Autoimmune lymphoproliferative syndrome
0 Companies
0 Drugs
Success rate
D062027:Linear iga bullous dermatosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
27%9/33
Phase 2
40%14/35
Phase 3
7%1/15
Approved: 0Overall Success rate: 1%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use